BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15493267)

  • 1. The phenotypic and molecular characterization of Nb2 lymphoma cells activated with IL-2 and human growth hormone.
    Cox JH; Lamb JR; Bal V; Butcher GW; Howard JC; Owen MJ; Ivanyi J
    Immunology; 1989 Jan; 66(1):83-9. PubMed ID: 15493267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate- and high-affinity interleukin-2 receptors expressed in an IL-4-dependent T-cell line induce different signals.
    Rebollo A; Silva A
    Immunology; 1993 Oct; 80(2):229-35. PubMed ID: 8262551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression.
    Chae DW; Nosaka Y; Strom TB; Maslinski W
    J Immunol; 1996 Oct; 157(7):2813-9. PubMed ID: 8816384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1 induces high affinity IL-2 receptor expression of CD4-8- thymocytes.
    Falk W; Männel DN; Darjes H; Krammer PH
    J Immunol; 1989 Jul; 143(2):513-7. PubMed ID: 2786909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirements for the induction of the interleukin-2 receptor complex in a human pre-T-cell line.
    Salvati PD; Peroni SE; Ranford PR; Kees UR
    Immunology; 1993 Mar; 78(3):449-54. PubMed ID: 8478026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax.
    Takatsuka N; Hasegawa A; Takamori A; Shimizu Y; Kato H; Ohashi T; Amagasa T; Masuda T; Kannagi M
    Int Immunol; 2009 Sep; 21(9):1089-100. PubMed ID: 19654198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymic origin of the prolactin-dependent Nb2 lymphoma cell line.
    Fleming WH; Pettigrew NM; Matusik RJ; Friesen HG
    Cancer Res; 1982 Aug; 42(8):3138-41. PubMed ID: 7046917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 (IL-2) production by human B-cell line.
    Katano M; Morisaki T; Matsuo T; Nakamura M; Kubota E; Hisatsugu T
    Cell Immunol; 1994 Dec; 159(2):262-70. PubMed ID: 7994758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of human oligodendrocytes to interleukin-2.
    Otero GC; Merrill JE
    Brain Behav Immun; 1997 Mar; 11(1):24-38. PubMed ID: 9193765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 production by human leukemia cell lines of pre-B cell origin.
    Holán V; Minowada J
    Neoplasma; 1993; 40(1):3-8. PubMed ID: 8350945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early immune response and regulation of IL-2 receptor subunits.
    Hughes-Fulford M; Sugano E; Schopper T; Li CF; Boonyaratanakornkit JB; Cogoli A
    Cell Signal; 2005 Sep; 17(9):1111-24. PubMed ID: 15993752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of common gamma-chain cytokines, interleukin-2, interleukin-7, and interleukin-15 for the in vitro generation of human tumor-reactive T lymphocytes for adoptive cell transfer therapy.
    Liu S; Riley J; Rosenberg S; Parkhurst M
    J Immunother; 2006; 29(3):284-93. PubMed ID: 16699371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells.
    Poggi A; Zocchi MR
    Hum Immunol; 2008 Nov; 69(11):755-9. PubMed ID: 18817823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning of IL-2R alpha, IL-2R beta, and IL-2R gamma cDNAs from a human oligodendroglioma cell line: presence of IL-2R mRNAs in the human central nervous system.
    Otero GC; Merrill JE
    Glia; 1995 Aug; 14(4):295-302. PubMed ID: 8530186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of functional interleukin-21 receptor on adult T-cell leukaemia cells.
    Ueda M; Imada K; Imura A; Koga H; Hishizawa M; Uchiyama T
    Br J Haematol; 2005 Jan; 128(2):169-76. PubMed ID: 15638850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium arsenite-induced inhibition of cell proliferation is related to inhibition of IL-2 mRNA expression in mouse activated T cells.
    Conde P; Acosta-Saavedra LC; Goytia-Acevedo RC; Calderon-Aranda ES
    Arch Toxicol; 2007 Apr; 81(4):251-9. PubMed ID: 17009048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 enhances the growth of human melanoma cells derived form primary but not from metastatic tumours.
    García-Vázquez MD; Boyano MD; Cañavate ML; Gardeazabal J; de Galdeano AG; López-Michelena T; Ratón JA; Izu R; Díaz-Ramón JL; Díaz-Pérez JL
    Eur Cytokine Netw; 2000 Dec; 11(4):654-61. PubMed ID: 11125310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.